Author:
Barker P. A.,Ashcroft G. W.,Binns J. K.
Abstract
Imipramine hydrochloride (N-(γ-dimethylaminopropyl)-iminodibenzyl hydrochloride, “Tofranil”) has been shown by many investigators to be of value in the treatment of depressive states. The reports of Kuhn (1957, 1958) and of Kielholz and Battegay (1958) have been followed by confirmatory papers from other authors. A number of contributors to the McGill University Symposium on Depression and Allied States (1959) commented favourably on the value of imipramine in depression; Hoff, however, while agreeing that the drug is useful in acute depressions stated that he found it ineffective in chronic depression.
Publisher
Royal College of Psychiatrists
Reference9 articles.
1. McGill University Conference on Depression and Allied States;Canad. Psychiat. Ass. J.,1959
2. Disturbance of Motor Function During Treatment with Imipramine
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tricyclic antidepressants;Meyler's Side Effects of Drugs;2016
2. Long-Term Impact of Residual Symptoms in Treatment-Resistant Depression;The Canadian Journal of Psychiatry;2011-09
3. ANTIDEPRESSANTS;Meyler's Side Effects of Psychiatric Drugs;2009
4. Tricyclic antidepressants;Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions;2006
5. Drug-induced ototoxicity;British Journal of Audiology;1988-01